Use of GnRH [gonadotropin-releasing hormone] antagonist (Cetrotide) [cetrorelix] protocol, instead of agonist, to prepare recipients for embryo transfer
Phase of Trial: Phase III
Latest Information Update: 27 Oct 2010
At a glance
- Drugs Cetrorelix; Leuprorelin
- Indications Infertility
- Focus Therapeutic Use
- 25 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 May 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 08 Nov 2008 Interim results were reported at the 64th Annual Meeting of the American Society for Reproductive Medicine.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History